Results 21 to 30 of about 466,412 (376)

Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [PDF]

Neurology Letters, 2023
Introduction: Most atypical inflammatory demyelinating diseases (IDD) exhibit pathological characteristics comparable to multiple sclerosis (MS). We conducted this systematic review to investigate the atypical cases that appear to be intermediate between
Sepideh Paybast, Fatemeh Baghalha, Ali Emami, Abdorreza Naser Moghadasi   +3 more
doaj  

Comparison of Neurite Orientation Dispersion and Density Imaging and Two-Compartment Spherical Mean Technique Parameter Maps in Multiple Sclerosis

Frontiers in Neurology, 2021
Background: Neurite orientation dispersion and density imaging (NODDI) and the spherical mean technique (SMT) are diffusion MRI methods providing metrics with sensitivity to similar characteristics of white matter microstructure.
Daniel Johnson, Daniel Johnson, Antonio Ricciardi, Antonio Ricciardi, Wallace Brownlee, Baris Kanber, Baris Kanber, Ferran Prados, Ferran Prados, Ferran Prados, Sara Collorone, Enrico Kaden, Enrico Kaden, Ahmed Toosy, Ahmed Toosy, Daniel C. Alexander, Claudia A. M. Gandini Wheeler-Kingshott, Claudia A. M. Gandini Wheeler-Kingshott, Claudia A. M. Gandini Wheeler-Kingshott, Olga Ciccarelli, Olga Ciccarelli, Francesco Grussu, Francesco Grussu   +22 more
doaj   +1 more source

The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D [PDF]

, 2012
The final version of this paper has been published in Multiple Sclerosis, 18 (6), June 2012 by SAGE Publications Ltd, All rights reserved. © It is available at: http:// msj.sagepub.com/Walking impairment has a major influence on the quality of life of ...
Brazier J, Canadian Agency for Drugs and Technologies in Health (CADTH), Crott R, EuroQol Group, Fischer J, Glick H, Gold M, Long J, National Institute for Health and Clinical Excellence, Pharmaceutical Benefits Advisory Committee, Round J, Royal College of Physicians MT, US Department of Health and Human Services Food and Drug Administration   +12 more
core   +2 more sources

Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community [PDF]

, 2023
Multiple sclerosis; Clinical course; ProgressionEsclerosis múltiple; Curso clínico; ProgresiónEsclerosi múltiple; Curs clínic; ProgressióBackground and Objectives: The current clinical course descriptors of multiple sclerosis (MS) include a combination ...
amato, Maria Pia, Calabresi, Peter, Finlayson, Marcia, Hawton, Annemarie, Moccia, Marcello, Montalban, Xavier, Thompson, Alan   +6 more
core   +1 more source

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS) [PDF]

International Journal of Molecular Sciences, 2020
Neutrophils are the most abundant circulating and first-responding innate myeloid cells and have so far been underestimated in the context of multiple sclerosis (MS). MS is the most frequent, immune-mediated, inflammatory disease of the central nervous system. MS is treatable but not curable and its cause(s) and pathogenesis remain elusive.
Niels Hellings, Mirre De Bondt, Mirre De Bondt, Ghislain Opdenakker, Sofie Struyf   +4 more
openaire   +4 more sources

Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial

Trials, 2021
Introduction Multiple sclerosis is a chronic inflammatory, degenerative disease of the central nervous system manifesting at first with relapses in about 85% of cases.
Anne Christin Rahn, Lisa Wenzel, Andrea Icks, Alexander Stahmann, Jutta Scheiderbauer, Kristina Grentzenberg, Markus Vomhof, Joseph Montalbo, Tim Friede, Christoph Heesen, Sascha Köpke   +10 more
doaj   +1 more source

Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial

Trials, 2021
An amendment to this paper has been published and can be accessed via the original article.
Anne Christin Rahn, Lisa Wenzel, Andrea Icks, Alexander Stahmann, Jutta Scheiderbauer, Kristina Grentzenberg, Markus Vomhof, Joseph Montalbo, Tim Friede, Christoph Heesen, Sascha Köpke   +10 more
doaj   +1 more source

Evaluation of an interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2): study protocol for a process evaluation accompanying a randomised controlled trial

BMJ Open, 2021
Introduction Process evaluations accompanying complex interventions examine the implementation process of the underlying intervention, identify mechanisms of impact and assess contextual factors.
Christoph Heesen, Sascha Köpke, Lisa Wenzel, Jutta Scheiderbauer, Markus van de Loo, Anne Christin Rahn   +5 more
doaj   +1 more source

“Undiagnosing” multiple sclerosis [PDF]

Neurology, 2012
To describe the clinical characteristics of encounters with patients misdiagnosed with multiple sclerosis (MS).A cross-sectional Internet-based physician survey of MS specialists was performed.The response rate for the survey was 50.4%. Of those who responded, the majority (95%) reported having evaluated 1 or more patients who had been diagnosed with ...
Andrew J. Solomon, Dennis Bourdette, Eran Klein   +2 more
openaire   +2 more sources

Sudden hearing loss as an early detector of multiple sclerosis: a systematic review [PDF]

, 2018
To evaluate whether Sudden Sensorineural Hearing Loss (S-SNHL) may be an early symptom of Multiple Sclerosis (MS). A systematic review was conducted using the following keywords: "Multiple sclerosis, hearing loss, sudden hearing loss, vertigo, tinnitus ...
Bernitsas, E, Di Stadio, A, Dipietro, L, Greco, A, Meneghello, F, Minni, A, Ralli, M, Stabile, M R   +7 more
core   +1 more source